Pages
#NHS75 – we need your help
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/nhs75-we-need-your-help
Clay Cross book group - looking for new members
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/clay-cross-book
Public invited to online NHS health meeting
https://dchs.nhs.uk/news/public-invited-online-nhs-health-meeting
Podcast guests wanted!
https://dchs.nhs.uk/my_dchs/show-me/staff-news-my-download/podcast-guests-wanted
Clay Cross Hospital
https://dchs.nhs.uk/our-services-and-locations/our-locations/community-hospitals/clay-cross-hospital
Files
2-Musculoskeletal Decision Making Tool Thinking about a Referral - KNEE.pdf
MSK Decision Making Tool - Knee
Appendix 11 - Adult Safeguarding Supervision Non-Case Discussion One to One - Group (P15)
Appendix 11 - Adult Safeguarding Supervision Non-Case Discussion One to One - Group (P15)
Tissue Viability Caseload Management Tool Kit Guidance (G213)
The overall aim of the Guidelines for the Tissue Viability Caseload Management Toolkit is to ensure that Tissue Viability Specialists manage their visits and patient caseloads in a standardised and auditable way across the whole of Tissue Viability Service. The covid19 pandemic has had a profound effect on how care and support for people is provided across all health and care settings thus this guidance has applied the learning from Covid19 to the review and development of the document
L75 - Deviated Toes Closing Wedge Osteotomy
L75 - Deviated Toes Closing Wedge Osteotomy. Podiatric Surgery patient information leaflet.
QPC ToR March 2024
QPC ToR March 2024
How to Record a Subject Access Request
How to Record a Subject Access Request
Podiatry Service Wound Care Health Care Assistant (HCA) Protocol (S114)
The purpose of this document is to provide guidance on the delegation of podiatry care to a Wound Care HCA.
A guide to what to do when someone has died (G316)
G316 - A guide to what to do when someone has died
How to check if a Purchase Order is receipted
How to check if a Purchase Order is receipted
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 2 of 2.pdf
Disclosure Ref 2024111 - Framework Agency Spend Jun 2023 to Mar 24 2 of 2.pdf